0
MAISON DE VITALITÉ
← All research profiles

Mitochondrial & cellular energy research

AICAR

Mechanistic research

AICAR commonly refers to acadesine in experimental work. Cells can convert it to ZMP, which resembles an energy-stress signal. It is not a peptide or a substitute for exercise.

Source review: September 9, 2026. Scientific evidence and trial records change over time.

01 · What is it?

The identity comes first.

AICAR commonly refers to acadesine in experimental work. Cells can convert it to ZMP, which resembles an energy-stress signal. It is not a peptide or a substitute for exercise.

Scientific classification: Non-peptide purine nucleoside analogue; research chemical

For example. It can resemble a low-battery message to an energy sensor, but it also affects processes outside that sensor.

02 · How does it work?

The signal, explained.

Cells can turn it into a molecule that resembles part of their low-energy signal. It can influence the AMPK energy sensor, but it also changes processes outside AMPK.

The key research focus is AMPK, indirectly through intracellular ZMP. A target describes where an interaction may occur; it does not by itself establish a benefit.

Learn the Science · mechanism

Cellular uptake and phosphorylation produce ZMP, an AMP analogue that can influence AMP-activated protein kinase. AICAR has AMPK-independent effects and is not a perfectly selective AMPK probe.

03 · What happens after the signal?

Follow the downstream effects.

AMPK can phosphorylate acetyl-CoA carboxylase and shift the balance between energy-consuming synthesis and energy-producing pathways. Cell type and experimental conditions determine the result.

To connect this mechanism to a real-world outcome, researchers need to establish exposure at the target, measure the response and test whether the change matters in a controlled human study.

04 · What is it commonly researched for?

The questions researchers are asking.

Research has explored energy sensing, glucose transport, lipid metabolism and ischemia-related pathways.

These are areas of investigation, not promises about a Maison product.

05 · Body systems involved

Where the biology connects.

Liver
A central site of nutrient handling, metabolic enzymes and selected downstream hormone responses.
Skeletal muscle
Relevant to energy use, mitochondrial activity or tissue-model endpoints.
Cardiovascular system
Relevant to vascular, cardiac or metabolic outcomes only within the research described.

06 · Receptor / target profile

The molecular reference card.

Primary receptor or target
AMPK, indirectly through intracellular ZMP
Secondary interactions
No additional primary target established for the research claim discussed.
Where it is found
Liver; Skeletal muscle; Cardiovascular system
Activation, inhibition or interaction
Cellular uptake and phosphorylation produce ZMP, an AMP analogue that can influence AMP-activated protein kinase. AICAR has AMPK-independent effects and is not a perfectly selective AMPK probe.
Important downstream pathways
AMPK can phosphorylate acetyl-CoA carboxylase and shift the balance between energy-consuming synthesis and energy-producing pathways. Cell type and experimental conditions determine the result.

07 · Evidence quality

What carries weight—and what does not.

STRONGER EVIDENCE

Convincing replicated human evidence for the broad wellness claims is not established.

EMERGING HUMAN EVIDENCE

Acadesine has historical human clinical research in specific settings. This does not validate bodybuilding or longevity use.

EARLY / PRECLINICAL EVIDENCE

The mechanistic observations described above do not establish the same outcomes in people.

UNKNOWN OR NOT WELL ESTABLISHED

Long-term outcomes, comparative benefit, clinically meaningful effects and safety for broad wellness use are not well established.

A familiar mechanism, a patent, a testimonial or a trial registration alone cannot establish human efficacy or product quality.

08 · Who is studying it?

Follow the original research.

No current sponsor-led clinical development program was verified for this exact research identity. This does not prove that no study exists; consult current records and distinguish related molecules.

Regulatory context: No approved medical use for this research identity was established in the sources reviewed. This is not a determination of authorization in every country. The research material discussed here must not be assumed equivalent to a licensed medicine.

VIEW CURRENT CLINICAL TRIALS

Registry links may include related compounds or historical studies. Read the exact intervention, sponsor, phase and latest update date. Recruitment status is specific to each trial.

09 · Research terminology

A small glossary for this page.

AMPK

A cellular enzyme complex that responds to energy availability.

ZMP

A phosphorylated AICAR metabolite that can mimic aspects of AMP signaling.

Phosphorylation

Adding a phosphate group, which can change a protein’s activity.

phosphorylation

Adding a phosphate group to a molecule, often changing its activity.

Biomarker

A measurable biological feature. A change in a marker does not always translate into a meaningful health outcome.

Target engagement

Evidence that a compound actually reaches and interacts with the intended biological target.

Randomized controlled trial

A study that assigns participants by chance to comparison groups, helping separate an intervention’s effects from other influences.

Explore the complete foundations glossary

10 · Research status & limitations

Keep the boundaries visible.

No approved medical use for this research identity was established in the sources reviewed. This is not a determination of authorization in every country. The research material discussed here must not be assumed equivalent to a licensed medicine.

Long-term outcomes, comparative benefit, clinically meaningful effects and safety for broad wellness use are not well established.

The main evidence category here is mechanistic research. The exact molecule, formulation, study population and endpoint matter. Scientific evidence changes; this page is a dated educational summary, not continuous trial monitoring.

11 · References / continue reading

Go to the source.

  1. Primary experiment · AICAR and hepatic AMPK
  2. Published study · PubMed 41294864

Individual study links support the associated research discussion. Literature-search links are clearly labelled and help you explore further; they are not themselves proof of a claim. Sponsor announcements should be read alongside published papers and current regulatory records.